Hasan Alanya

Hasan Alanya is a Researcher in the Department of Neurosurgery at Yale School of Medicine. His work focuses on genomic characterization of brain tumors, including meningiomas, pituitary adenomas, and other neurological disorders. He specializes in molecular pathology, somatic mutations, and the genetic basis of tumor behavior. His research bridges clinical neurosurgery with advanced genomic techniques to understand tumor progression and racial/ethnic variations in disease outcomes.

Key research interests include neuro-oncology, somatic mutation analysis, and translational applications of genomic data. His studies investigate how genetic mutations drive tumor development and response to therapy, particularly in pituitary and spinal tumors. Recent work emphasizes the role of thrombocytes in immune responses and the utility of single-cell data for refining bulk genomic analyses.

Publications highlight interdisciplinary approaches, combining genomics with clinical observations to address gaps in understanding tumor heterogeneity and treatment strategies. Collaborations span neurosurgery, oncology, and computational biology to advance personalized medicine in neuro-oncology.